Efficacy and Safety of Zuojin Pill for the Treatment of Chronic Nonatrophic Gastritis: A Randomized Active-Controlled Clinical Trial

Table 1

Comparison of baseline characteristics (mean ± SD).

Variables	Zuojin pill (n = 34)	Marzulene-S granule (n = 34)	value
Gender (male/female)	22/12	17/17	0.327
Age	56.20 ± 9.33	53.91 ± 10.92	0.355
Red plaques	2.09 ± 0.83	2.15 ± 0.92	0.770
Erosion	2.09 ± 0.83	2.15 ± 0.66	0.747
Hemorrhage	1.62 ± 1.10	1.38 ± 0.95	0.350
Bile reflux	1.65 ± 0.69	1.76 ± 0.85	0.535
Chronic inflammation	2.35 ± 0.64	2.26 ± 0.66	0.581
Active chronic inflammation	2.20 ± 0.81	2.06 ± 0.78	0.447
Positive Hp rate	15 (44.1%)	18 (52.9%)	0.628
Abdominal distension	2.82 ± 0.39	2.68 ± 0.59	0.228
Belching	2.15 ± 0.36	2.29 ± 0.46	0.148
Nausea and vomiting	2.47 ± 0.67	2.38 ± 0.74	0.594
Loss of appetite	2.79 ± 0.50	2.76 ± 0.50	0.804

Notes: Hp, Helicobacter pylori.